"The Board continue to work with Piper Jaffray with the intention of extending the commercialisation of laninamivir and Biota?s other products in development. Piper Jaffray?s advice will centre on the best route to maximise and release shareholder value through merger, acquisition or listing opportunities available to the Company. Shareholders will continue to be updated at key events."
investigating best route to maximise shareholder value including through merger. thought that might have sparked some comment?
BTA Price at posting:
89.0¢ Sentiment: LT Buy Disclosure: Held
